Sirio Pharma (300791) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.035x

Based on the latest financial reports, Sirio Pharma (300791) has a cash flow conversion efficiency ratio of 0.035x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.61 Million ≈ $14.87 Million USD) by net assets (CN¥2.91 Billion ≈ $425.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sirio Pharma - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sirio Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sirio Pharma (300791) financial obligations for a breakdown of total debt and financial obligations.

Sirio Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sirio Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cybrid Technologies Inc SHG:603212	0.039x
UNITIL Corporation NYSE:UTL	0.026x
MilDef Group AB ST:MILDEF	0.048x
JDM Jingda Mach(Ningbo)Co Ltd SHG:603088	0.077x
RHÖN-KLINIKUM Aktiengesellschaft XETRA:RHK	-0.019x
Indian Metals & Ferro Alloys Limited NSE:IMFA	0.131x
Anhui Huilong Agricultural Means of Production Co Ltd SHE:002556	0.153x
Cowealth Medical China Co.Ltd. SHG:603122	N/A

Annual Cash Flow Conversion Efficiency for Sirio Pharma (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sirio Pharma from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Sirio Pharma.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.64 Billion ≈ $386.49 Million	CN¥566.97 Million ≈ $82.97 Million	0.215x	+42.68%
2023-12-31	CN¥2.57 Billion ≈ $375.51 Million	CN¥386.08 Million ≈ $56.50 Million	0.150x	-8.63%
2022-12-31	CN¥2.70 Billion ≈ $395.32 Million	CN¥444.86 Million ≈ $65.10 Million	0.165x	+22.75%
2021-12-31	CN¥2.54 Billion ≈ $372.38 Million	CN¥341.38 Million ≈ $49.95 Million	0.134x	-8.38%
2020-12-31	CN¥2.18 Billion ≈ $319.40 Million	CN¥319.57 Million ≈ $46.76 Million	0.146x	+22.96%
2019-12-31	CN¥1.95 Billion ≈ $284.62 Million	CN¥231.60 Million ≈ $33.89 Million	0.119x	-49.11%
2018-12-31	CN¥784.05 Million ≈ $114.73 Million	CN¥183.46 Million ≈ $26.85 Million	0.234x	+175.08%
2017-12-31	CN¥580.20 Million ≈ $84.90 Million	CN¥49.35 Million ≈ $7.22 Million	0.085x	+140.25%
2016-12-31	CN¥464.98 Million ≈ $68.04 Million	CN¥-98.26 Million ≈ $-14.38 Million	-0.211x	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$876.92 Million

CN¥5.99 Billion CNY

Market Cap Rank

#9714 Global

#2726 in China

Share Price

CN¥19.50

Change (1 day)

+0.36%

52-Week Range

CN¥18.79 - CN¥31.81

All Time High

CN¥57.47